These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
71 related articles for article (PubMed ID: 4912331)
1. [Immunopathological model of the development of demyelinating encephalomyelitides]. Schmidt RM; Diessner H Psychiatr Neurol Med Psychol (Leipz); 1970 Jan; 22(1):18-22. PubMed ID: 4912331 [No Abstract] [Full Text] [Related]
2. [Autoimmunologic aspects of demyelinating encephalitides]. Seitelberger F Nervenarzt; 1967 Dec; 38(12):525-35. PubMed ID: 6082169 [No Abstract] [Full Text] [Related]
3. [Experimental allergic encephalomyelitis as model of a neuro-allergic disease]. Hitzschke B; Meyer-Rienecker H; Sayk J; Schröter P Z Arztl Fortbild (Jena); 1969 Dec; 63(24):1315-20. PubMed ID: 5403442 [No Abstract] [Full Text] [Related]
4. [Non-demyelinating ophthalmo-encephalomyelitis with a chronic evolution in bursts]. Vuia O; Seitan I; Alexianu M Acta Neurol Psychiatr Belg; 1967 Jul; 67(7):567-82. PubMed ID: 4964295 [No Abstract] [Full Text] [Related]
5. [Immunological reactions and problems of immunosuppression in experimental and clinical forms of demyelinating diseases]. Cendrowski W Neurol Neurochir Pol; 1971; 5(2):133-6. PubMed ID: 5576472 [No Abstract] [Full Text] [Related]
6. [On the problem of immunopathological processes in demyelinizing encephalomyelitis]. Schrader A Ther Umsch; 1966 May; 23(5):204-7. PubMed ID: 5982608 [No Abstract] [Full Text] [Related]
7. Suppressive effect on Theiler's murine encephalomyelitis virus-induced demyelinating disease by the administration of anti-IL-12 antibody. Inoue A; Koh CS; Yamazaki M; Yahikozawa H; Ichikawa M; Yagita H; Kim BS J Immunol; 1998 Nov; 161(10):5586-93. PubMed ID: 9820536 [TBL] [Abstract][Full Text] [Related]
8. [Therapeutic options for autoimmune encephalomyelitis]. Borisow N; Prüss H; Paul F Nervenarzt; 2013 Apr; 84(4):461-5. PubMed ID: 23568167 [TBL] [Abstract][Full Text] [Related]
9. Possible mechanisms in the pathogenesis of "postinfectious" encephalomyelitis. Harter DH; Choppin PW Res Publ Assoc Res Nerv Ment Dis; 1971; 49():342-55. PubMed ID: 4332337 [No Abstract] [Full Text] [Related]
10. Pathogenesis and treatment of central nervous system demyelinating disease. Zamvil SS; Soos JM; Weiner HL Rev Neurol (Paris); 1998 Sep; 154(8-9):573-5. PubMed ID: 9809371 [No Abstract] [Full Text] [Related]
16. The immunoallergic significance of the perivascular cellular infiltrate in primary human demyelinating encephalomyelitis. Duma D; Papilian VV; Popovici L; Serban M; Popovicic L Rom Med Rev; 1966; 20(2):35-41. PubMed ID: 5960043 [No Abstract] [Full Text] [Related]
18. Immune regulation of coronavirus-induced demyelinating encephalomyelitis. Stohlman SA; Lin M; Parra B; Bergmann CC; Hinton DR J Neurovirol; 1997 May; 3 Suppl 1():S56-7. PubMed ID: 9179796 [No Abstract] [Full Text] [Related]
19. [Past hepatitis B virus infection and demyelinating multiphasic disease: casual or causal relationship?]. Santos-García D; Arias-Rivas S; Dapena D; Arias M Neurologia; 2007 Oct; 22(8):542-6. PubMed ID: 17602335 [TBL] [Abstract][Full Text] [Related]
20. [Auto-aggressive diseases of the skin]. Marghescu S Wien Med Wochenschr; 1970 Nov; 120(45):779-84. PubMed ID: 4933372 [No Abstract] [Full Text] [Related] [Next] [New Search]